Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Pável E Olivera, MD, César A Velasquez, MD, Desirée Campoy, MD, Gonzalo Artaza, MD, Tania Canals, MD, Katia Flores, MD, Silvia Ruiz, MD, Alessandra Comai, MD, Erik A Johansson, MD, Gabriela S Ene, MD PhD, Gabriela Bastidas, MD, Maricel Subira, MD PhD, Jorge Sierra, MD, Ramón Salinas, MD PhD

Blood (2019) 134 (Supplement_1): 3661.

https://doi.org/10.1182/blood-2019-128300

Published: 2019

Journal Articles

Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Alma R. Oskarsdottir, MD, Brynja R. Gudmundsdottir, MS, Pall T. Onundarson, MD

Blood (2018) 132 (Supplement 1): 1239.

https://doi.org/10.1182/blood-2018-99-116731

Published: 2018

Journal Articles

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

Lai Heng Lee, MBBS,FRCP, Ming Chai Kong, Isabelle Teo, Shun Wei Lim, Jin Shing Hon, Kelly Bee Ling Chng, Sing Lin Tee, Elicia Purnata, Clifton You Xuan Liew, Xin Hui Loh, Cui Mei Fong, Nirmali Ruth Sivapragasam, Yiong Huak Chan, Jiang Ming Fam, Heng Joo Ng, Marcus Eng Hock Ong, David Bruce Matchar

Blood (2017) 130 (Supplement 1): 3719.

https://doi.org/10.1182/blood.V130.Suppl_1.3719.3719

Published: 2017

Journal Articles

Oral Anticoagulant Dosing, Administration, and Storage: A Cross-Sectional Survey of Canadian Health Care Providers

Siavash Piran, MD MSc, Sam Schulman, MD PhD FRCPC, Mohamed Panju, MD MSc, FRCPC, Menaka Pai, BSc,MDFRCPC,MSc

Blood (2017) 130 (Supplement 1): 5593.

https://doi.org/10.1182/blood.V130.Suppl_1.5593.5593

Published: 2017

Journal Articles

Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis

Chatree Chai-Adisaksopha, MD, Christopher M Hillis, MD FRCPC, Daniel M. Witt, PharmD, FCCP, BCPS, Sam Schulman, MD PhD FRCPC, Mark Crowther, MD, Alfonso Iorio, MD PhD

Blood (2016) 128 (22): 3821.

https://doi.org/10.1182/blood.V128.22.3821.3821

Published: 2016

Journal Articles

VWF Multimer Quantitation for Assessment of Cardiac Lesion Severity and Bleeding Risk

Justin Bryan, BS, Christopher Austin, MD, Colleen Thomas, Robert E. Safford, MD PhD, Dong Chen, MD PhD, Joseph Blackshear, MD

Blood (2016) 128 (22): 2588.

https://doi.org/10.1182/blood.V128.22.2588.2588

Published: 2016

Journal Articles

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

Mashrafi Ahmed, MD, Ashok R. Patel, MD

Blood (2015) 126 (23): 4540.

https://doi.org/10.1182/blood.V126.23.4540.4540

Published: 2015

Journal Articles

Initial Experience with 4-Factor PCC for the Reversal of Warfarin: Patterns of Use and Safety Outcomes

Colleen T. Morton, David J Dries, MD, Fatima Khan, MBBS

Blood (2014) 124 (21): 2867.

https://doi.org/10.1182/blood.V124.21.2867.2867

Published: 2014

Journal Articles

Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent

Petra Jilma-Stohlawetz, MD, Schima Heinrich, PhD, Martin Stoiber, Peter Quehenberger, MD, Sabine Schranz, RN, Bernd Jilma, MD

Blood (2013) 122 (21): 3602.

https://doi.org/10.1182/blood.V122.21.3602.3602

Published: 2013

Journal Articles

Thrombin Generation Measurement In Whole Blood As a Control For Vitamin K Antagonist Treatment - Effect Of Thrombomodulin

Saartje Bloemen, Marieke de Laat, Arina ten Cate-Hoek, Hugo ten Cate, Bas De Laat, PhD, H. Coenraad Hemker, PhD, Raed Al Dieri, PhD

Blood (2013) 122 (21): 3646.

https://doi.org/10.1182/blood.V122.21.3646.3646

Published: 2013

Journal Articles

Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population

Susan I. Vear, MD, Gregory D. Ayers, MS, C. Michael Stein, MD, MBChB, Richard H. Ho, MD, MSCI

Blood (2012) 120 (21): 4358.

https://doi.org/10.1182/blood.V120.21.4358.4358

Published: 2012

Journal Articles

Evaluation of Prosthetic Valve Function by Platelet Function Analysis and Von Willebrand Factor Indices

Ewa M. Wysokinska, MD, Katherine M. Duello, MD, Dong Chen, MD, PhD, Joseph L Blackshear, MD

Blood (2012) 120 (21): 1128.

https://doi.org/10.1182/blood.V120.21.1128.1128

Published: 2012

Journal Articles

A Tertiary Care University Hospital Thrombosis Consultation Service: Patient Volume and Characteristics, Requesting Service and Reason for Consult

Rufaro S. Chitsike, MD, Mark Blostein, Vicky Tagalakis, MD, MSc, Andrew Hirsch, April Shamy, MD, FRCP(C), Chantal Cassis, MD, Vicky Springmann, Susan R. Kahn, MD, MSc

Blood (2011) 118 (21): 4751.

https://doi.org/10.1182/blood.V118.21.4751.4751

Published: 2011

Journal Articles

Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study

Emma Jones, MD, Mary Bauman, RN, BA, M. Patricia Massicotte, MD, Brian Gage, MD, Ebony Courtney, MA, Lisa Bomgaars, MD

Blood (2008) 112 (11): 988.

https://doi.org/10.1182/blood.V112.11.988.988

Published: 2008

Journal Articles

Seven-Year Follow up of An Inception Cohort Study of Patients with Atrial Fibrillation Starting Oral Anticoagulation: Aging as An Independent Bleeding Risk

Patricia Casais, MD, PhD

Blood (2008) 112 (11): 4045.

https://doi.org/10.1182/blood.V112.11.4045.4045

Published: 2008

Journal Articles

Lack of Drug-Drug Interaction Between ATI-5923, a Novel Vitamin K Epoxide Reductase Inhibitor, and Amiodarone, in Beagle Dog

Anges Choppin, Ph.D, Ian Irwin, Leang Lach, Adrian Davies, Ph.D, Lei Shao, Ph.D, Cyrus Becker, Monica P. Palme, Ph.D, Xavier Paliard, Ph.D, Scott Bowersox, Ph.D, Donn Dennis, Paliard Druzgala, Ph.D

Blood (2008) 112 (11): 5338.

https://doi.org/10.1182/blood.V112.11.5338.5338

Published: 2008

Journal Articles

The Feasibility and Safety of Anticoagulation during Chemotherapy Associated Thrombocytopenia for Thrombotic Complications of Malignancy.

Mark N. Polizzotto, MD, Stephen S. Opat, MD

Blood (2007) 110 (11): 1872.

https://doi.org/10.1182/blood.V110.11.1872.1872

Published: 2007

Journal Articles

Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.

Alexander G. Turpie, MD, James D. Douketis, MD

Blood (2004) 104 (11): 703.

https://doi.org/10.1182/blood.V104.11.703.703

Published: 2004

Journal Articles

The Risk of Hemorrhage and the Frequency of Vitamin K Use in Asymptomatic Patients with Warfarin-Associated Coagulopathy.

David A. Garcia, MD, Mark A. Crowther, MD, Elaine M. Hylek, MD

Blood (2004) 104 (11): 527.

https://doi.org/10.1182/blood.V104.11.527.527

Published: 2004

NARROW

Effectiveness and Safety of Direct Oral Anticoagulants Vs. Low Molecular Weight Heparin As Anticoagulant Therapy in Patients with Active Cancer Therapy and Non Valvular Atrial Fibrillation

Replacing PT-INR Monitoring of Warfarin with Fiix-NR in Clinical Practice Reduces Thromboembolism without Increasing Bleeding Despite Reduced Number of Dose Adjustments

Optimal International Normalized Ratio Range for Asian Patients on Anticoagulation Therapy

Oral Anticoagulant Dosing, Administration, and Storage: A Cross-Sectional Survey of Canadian Health Care Providers

Warfarin Resumption after Intracranial Hemorrhage: A Systematic Review and Meta-Analysis

VWF Multimer Quantitation for Assessment of Cardiac Lesion Severity and Bleeding Risk

Evaluation of Normal Reference Range of Schistocytes and Burr Cells in Healthy Adults

Initial Experience with 4-Factor PCC for the Reversal of Warfarin: Patterns of Use and Safety Outcomes

Acquired Von Willebrand Factor Deficiency Caused By Left Ventricular Assist Devices Is Adamts-13 Dependent

Thrombin Generation Measurement In Whole Blood As a Control For Vitamin K Antagonist Treatment - Effect Of Thrombomodulin

Polymorphisms in VKORC1, CYP2C9, and CYP4F2 and Warfarin Dose in the Pediatric Population

Evaluation of Prosthetic Valve Function by Platelet Function Analysis and Von Willebrand Factor Indices

A Tertiary Care University Hospital Thrombosis Consultation Service: Patient Volume and Characteristics, Requesting Service and Reason for Consult

Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study

Seven-Year Follow up of An Inception Cohort Study of Patients with Atrial Fibrillation Starting Oral Anticoagulation: Aging as An Independent Bleeding Risk

Lack of Drug-Drug Interaction Between ATI-5923, a Novel Vitamin K Epoxide Reductase Inhibitor, and Amiodarone, in Beagle Dog

The Feasibility and Safety of Anticoagulation during Chemotherapy Associated Thrombocytopenia for Thrombotic Complications of Malignancy.

Enoxaparin Is Effective and Safe as Bridging Anticoagulation in Patients with a Mechanical Prosthetic Heart Valve who Require Temporary Interruption of Warfarin because of Surgery or an Invasive Procedure.

The Risk of Hemorrhage and the Frequency of Vitamin K Use in Asymptomatic Patients with Warfarin-Associated Coagulopathy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only